New Zealand markets closed

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1900-0.1400 (-6.01%)
At close: 04:00PM EST
2.2300 +0.04 (+1.83%)
After hours: 07:55PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.3300
Open2.2900
Bid2.1900 x 39400
Ask2.2500 x 27000
Day's range2.1800 - 2.4000
52-week range2.1800 - 11.1000
Volume5,633,389
Avg. volume3,894,179
Market cap259.318M
Beta (5Y monthly)1.58
PE ratio (TTM)N/A
EPS (TTM)-2.7810
Earnings date23 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.33
  • Motley Fool

    2 Cancer Stocks With Absurdly Low Valuations

    The potential for four or more interest rate hikes by the Federal Reserve over the course of 2022 has been weighing heavily on growth stocks of late. Investors are clearly pivoting toward safe havens like value and dividend stocks ahead of this perceived eventuality. Shares of the cancer specialists Adaptimmune Therapeutics (NASDAQ: ADAP) and Clovis Oncology (NASDAQ: CLVS) are both trading at absurdly low valuations following their steep downturns over the past several weeks.

  • Business Wire

    Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021

    BOULDER, Colo., January 10, 2022--Clovis Oncology, Inc. (NASDAQ:CLVS) today announced its preliminary, unaudited global product revenues for the fourth quarter and full year ended December 31, 2021. The financial information presented in this news release may be adjusted as a result of completion of customary quarterly review and audit procedures.

  • Zacks

    Is the Options Market Predicting a Spike in Clovis Oncology (CLVS) Stock?

    Investors need to pay close attention to Clovis Oncology (CLVS) stock based on the movements in the options market lately.